Abstract:Abstract Combining multiple types of genomic, transcriptional, proteomic, and epigenetic datasets has the potential to reveal biological mechanisms across multiple scales, and may lead to more accurate models for clinical decision support. Developing efficient models that can derive clinical outcomes from high-dimensional data remains problematical; challenges include the integration of multiple types of omics data, inclusion of biological background knowledge, and developing machine learning models that are able to deal with this high dimensionality while having only few samples from which to derive a model. We developed DeepMOCCA, a framework for multi-omics cancer analysis. We combine different types of omics data using biological relations between genes, transcripts, and proteins, combine the multi-omics data with background knowledge in the form of protein–protein interaction networks, and use graph convolution neural networks to exploit this combination of multi-omics data and background knowledge. DeepMOCCA predicts survival time for individual patient samples for 33 cancer types and outperforms most existing survival prediction methods. Moreover, DeepMOCCA includes a graph attention mechanism which prioritizes driver genes and prognostic markers in a patient-specific manner; the attention mechanism can be used to identify drivers and prognostic markers within cohorts and individual patients. Author summary Linking the features of tumors to a prognosis for the patient is a critical part of managing cancer. Many methods have been applied to this problem but we still lack accurate prognostic markers for many cancers. We now have more information than ever before on the state of the cancer genome, the epigenetic changes in tumors, and gene expression at both RNA and protein levels. Here, we address the question of how this data can be used to predict cancer survival and discover which tumor genes make the greatest contribution to the prognosis in individual tumor samples. We have developed a computational model, DeepMOCCA, that uses artificial neural networks underpinned by a large graph constructed from background knowledge concerning the functional interactions between genes and their products. We show that with our method, DeepMOCCA can predict cancer survival time based entirely on features of the tumor at a cellular and molecular level. The method confirms many existing genes that affect survival but for some cancers suggests new genes, either not implicated in survival before or not known to be important in that particular cancer. The ability to predict the important features in individual tumors provided by our method raises the possibility of personalized therapy based on the gene or network dominating the prognosis for that patient.

Predicting implicit associated cancer genes from OMIM and MEDLINE by a new probabilistic model

Application Of A New Probabilistic Model For Mining Implicit Associated Cancer Genes From Omim And Medline

A Probabilistic Model for Mining Implicit 'chemical Compound-Gene' Relations from Literature

Towards Prediction and Prioritization of Disease Genes by the Modularity of Human Phenome-Genome Assembled Network.

2286-PUB: Profiling MicroRNA (mirna) and Metabolic Disease Association by Using Diffusion Model

Novel Potential Small Molecule-MiRNA-Cancer Associations Prediction Model Based on Fingerprint, Sequence, and Clinical Symptoms

Inference of pan-cancer related genes by orthologs matching based on enhanced LSTM model

Mining Disease-Specific Molecular Association Profiles from Biomedical Literature: A Case Study

SMMDA: Predicting miRNA-Disease Associations by Incorporating Multiple Similarity Profiles and a Novel Disease Representation

HGIMDA: Heterogeneous Graph Inference for Mirna-Disease Association Prediction

Identifying driver pathways based on a parameter-free model and a partheno-genetic algorithm

Predicting MiRNA-disease associations by multiple meta-paths fusion graph embedding model

DeepMOCCA: A pan-cancer prognostic model identifies personalized prognostic markers through graph attention and multi-omics data integration

Pathogenic Gene Prediction Algorithm Based on Heterogeneous Information Fusion.

Supplementary Material For: Inferring Gene-Disease Association by an Integrative Analysis of Eqtl Genome-Wide Association Study and Protein-Protein Interaction Data

Inferring Gene-Disease Association by an Integrative Analysis of eQTL Genome-Wide Association Study and Protein-Protein Interaction Data.

Discovery of Bladder Cancer-related Genes Using Integrative Heterogeneous Network Modeling of Multi-omics Data

Predicting BRCA mutation and stratifying targeted therapy response using multimodal learning: a multicenter study

CanPredict: a Computational Tool for Predicting Cancer-Associated Missense Mutations

Probability-based collaborative filtering model for predicting gene–disease associations

PBMDA: A Novel and Effective Path-Based Computational Model for Mirna-Disease Association Prediction